Farther Finance Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.4K | Buy |
68
+10
| +17% | +$2.41K | ﹤0.01% | 2795 |
|
|
2025
Q1 | $13.9K | Sell |
58
-58
| -50% | -$13.9K | ﹤0.01% | 2576 |
|
|
2024
Q4 | $38.1K | Sell |
116
-11
| -9% | -$3.61K | ﹤0.01% | 1791 |
|
|
2024
Q3 | $42.5K | Buy |
127
+26
| +26% | +$8.7K | ﹤0.01% | 1738 |
|
|
2024
Q2 | $26.7K | Sell |
101
-51
| -34% | -$13.5K | ﹤0.01% | 1669 |
|
|
2024
Q1 | $51.5K | Buy |
152
+41
| +37% | +$13.9K | ﹤0.01% | 1181 |
|
|
2023
Q4 | $35.8K | Buy |
111
+32
| +41% | +$10.3K | ﹤0.01% | 1147 |
|
|
2023
Q3 | $28.3K | Sell |
79
-22
| -22% | -$7.89K | ﹤0.01% | 985 |
|
|
2023
Q2 | $38.3K | Buy |
101
+30
| +42% | +$11.4K | 0.01% | 751 |
|
|
2023
Q1 | $34K | Buy |
71
+13
| +22% | +$6.23K | 0.01% | 726 |
|
|
2022
Q4 | $24.4K | Buy |
+58
| New | +$24.4K | 0.01% | 671 |
|